NHD Global
Continue from catalog navigation into editorial analysis, evidence records and quality-documentation guidance.
Showing 7–12 of 12 reviewed articles · Page 2 of 2
Oxytocin is a cyclic nonapeptide with a Cys1–Cys6 disulfide bridge and a C-terminal amide. Sequence, disulfide state, counterion, aggregation and potency are…
Lire la revue des sources →Oxytocin is both an endogenous hormone and a regulated prescription drug. Established obstetric uses do not validate every social, mood, bonding or…
Lire la revue des sources →Kisspeptin-10 est le décapeptide C-terminal YNWNSFGLRF-amide. Il partage une région C-terminale active avec des kisspeptines plus longues, mais ce n'est pas le même matériau que…
Lire la revue des sources →A 2011 study established that kisspeptin-10 can acutely stimulate luteinizing-hormone secretion in healthy men. Its detailed pulse data are valuable physiology, but…
Lire la revue des sources →PT-141 is the development code associated with bremelanotide. A free-base peptide, its acetate form and the approved finished injection are related records,…
Lire la revue des sources →Bremelanotide has a real FDA-approved finished-drug record, but its scope is narrow. The RECONNECT trials studied premenopausal women with acquired, generalized HSDD—not…
Lire la revue des sources →If a target is not listed, submit the sequence, scale and specification for a custom-project feasibility review.
Indiquez-nous vos besoins. Votre demande sera transmise à l’interlocuteur compétent pour les références, la disponibilité et les détails du devis.
